FT.com / Search

1-10 of 52,991 results for Hillcrest Laboratories, Inc.

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

September 28, 2009
Abbott Laboratories / Solvay
...From the Chicago suburbs to the streets of Brussels, Abbott Laboratories’ €4.5bn cash acquisition of Solvay’s drugs business...some of its zero-yielding cash. BACKGROUND NEWS Abbott Laboratories on Monday announced the €4.5bn ($6.6bn) acquisition...
February 8, 2010
Alliance to buy Cambridge Laboratories
Alliance Pharma, the speciality drug company, is to buy the bulk of Cambridge Laboratories in a deal valued at between £14m and £16m that will be part-funded with a share placing by Alliance.“It’s a business... By John O’Doherty
January 25, 2010
US bank stocks bounce back
...businesses replace their computers. The shares rose 2.1 per cent at $20.32. Barron’s also gave a boost to Forest Laboratories, saying the drugmaker’s shares could also gain 25 per cent over the next year due to higher revenues from its latest... By Samantha Pearson in New York
November 12, 2009
Barclays hires Landgarten for healthcare
...head Patrick McMullan in overseeing Barclays Capital’s relationships with healthcare clients such as Pfizer, Abbott Laboratories and Warner Chilcott. “We’re pleased to welcome a healthcare banker of Rick’s calibre to the firm, particularly... By Justin Baer in New York
January 25, 2006
Strong results boost Abbott Laboratories
Abbott Laboratories’ shares rose on Wednesday as the US medical products group, a winner in the bid battle over Guidant, reported strong fourth... By Christopher Bowe in New York
September 27, 2009
Abbott in €4.5bn deal for Solvay drug unit
Abbott Laboratories on Monday announced the €4.5bn ($6.6bn) acquisition of Solvay’s pharmaceutical company, bringing a five-month... By Lina Saigol in London
September 28, 2009
Wall Street rallies on deal activity
...Street on Monday recorded its biggest daily gain for over a month after merger deals lifted investor confidence. Abbott Laboratories agreed to pay $6.6bn in cash for the drugs unit of Belgian rival Solvay, bringing to an end a five-month takeover battle... By Samantha Pearson in New York
September 24, 2009
Battle for Solvay division nears end
...conclusion on Friday at a board meeting of the Belgian group, underlining the continued consolidation in the drug sector. Abbott Laboratories of the US has edged ahead of UCB of Belgium and Nycomed of Switzerland in the contest, according to people close to the situation... By Lina Saigol and Martin Arnold in London
September 29, 2009
Chemicals
...Solvay, the Belgian chemicals conglomerate, plans to do following the sale of its pharmaceuticals unit to the US’s Abbott Laboratories this week. The decision to reinvest the proceeds, rather than pay a special dividend, suggests that Solvay’s board remains...
November 14, 2009
Grandma knows best when it comes to drugs
...medicine if it has been round for a while,” said Andrew Livingstone of Forest Laboratories. “Would it be round for 60 years if it didn’t work?” Forest Laboratories’ UK division bought the Bisodol brand of indigestion products from Wyeth... By John O’Doherty